iANTHUS CAPITAL HOLDINGS (ITHUF) Non-Current Deferred Tax Liability (2020 - 2024)
iANTHUS CAPITAL HOLDINGS's (ITHUF) quarterly Non-Current Deferred Tax Liability came in at $15.8 million in Q3 2024, down 33.51% year-on-year from $23.8 million in Q4 2023, and down 9.55% quarter-over-quarter from $17.5 million in Q2 2024.
iANTHUS CAPITAL HOLDINGS (ITHUF) Non-Current Deferred Tax Liability (2020 - 2024) Analysis & Trends
iANTHUS CAPITAL HOLDINGS has disclosed Non-Current Deferred Tax Liability across 5 years of filings, most recently posting $15.8 million for Q3 2024.
- Non-Current Deferred Tax Liability for Q3 2024 came in at $15.8 million, down 33.51% year-over-year; the trailing twelve-month figure through Sep 2024 was $15.8 million (down 33.51% YoY), and the FY2023 annual result was $20.4 million, down 14.29% from the prior year.
- Non-Current Deferred Tax Liability came in at $15.8 million for Q3 2024 at iANTHUS CAPITAL HOLDINGS, down from $17.5 million in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $37.6 million in Q4 2020 to a low of $15.8 million in Q3 2024.
- The 5-year median for Non-Current Deferred Tax Liability is $25.7 million (2021), against an average of $26.4 million.
- Across the five-year window, Non-Current Deferred Tax Liability slipped 1.66% in 2022 and slumped 33.51% in 2024, its largest moves.
- iANTHUS CAPITAL HOLDINGS's Non-Current Deferred Tax Liability stood at $37.6 million in 2020, then decreased by 26.89% to $27.5 million in 2021, then dropped by 13.42% to $23.8 million in 2022, then declined by 14.29% to $20.4 million in 2023, then declined by 22.59% to $15.8 million in 2024.
- The last three Non-Current Deferred Tax Liability figures came in at $15.8 million (Q3 2024), $17.5 million (Q2 2024), and $17.9 million (Q1 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | iANTHUS CAPITAL HOLDINGS | - | - | 15.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 15.80 Mn |
| Sep 30, 2024 | 15.80 Mn |
| Jun 30, 2024 | 17.47 Mn |
| Jun 30, 2024 | 17.47 Mn |
| Mar 31, 2024 | 17.91 Mn |
| Mar 31, 2024 | 17.91 Mn |
| Dec 31, 2023 | 20.41 Mn |
| Dec 31, 2023 | 20.41 Mn |
| Sep 30, 2023 | 23.76 Mn |
| Sep 30, 2023 | 23.76 Mn |
| Jun 30, 2023 | 23.76 Mn |
| Jun 30, 2023 | 23.76 Mn |
| Mar 31, 2023 | 23.78 Mn |
| Mar 31, 2023 | 23.78 Mn |
| Dec 31, 2022 | 23.82 Mn |
| Dec 31, 2022 | 23.82 Mn |
| Sep 30, 2022 | 31.60 Mn |
| Sep 30, 2022 | 31.60 Mn |
| Jun 30, 2022 | 31.60 Mn |
| Jun 30, 2022 | 31.60 Mn |